In this week’s Homerun Slides from Dr. Stanley Schwartz, we look into exactly what a more aggressive therapy towards treating diabetes might look like with a review of dual and triple therapy approaches as well as which medications can be used and when. We also examine the cardiovascular impact of these …
Read More »Acarbose Higher Cardiovascular Risk Than Metformin
According to a new retrospective study acarbose may not have a cardioprotective effect as good as metformin when used as first-line therapy… This study analyzed 17,366 patients who initiated acarbose therapy and 230,023 who initiated metformin therapy. Both nephropathy and diabetes complication severity index were strongly associated with the patients …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 15
In this week’s Homerun Slides, we continue our exploration of the positive effects of Ranolazine, which is used to treat angina, and then begin to focus in on therapies for type 2 patients with cardiovascular concerns… To download these slides in PowerPoint (.ppt) format, use this link: Diabetes Mellitus 101 for Cardiologists, Part …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 14
In this week’s Homerun Slides, we focus in on the specifics of the drug, Ranolazine, which is used to treat angina, and its effects on patients with diabetes… To download these slides in PowerPoint (.ppt) format, use this link: Diabetes Mellitus 101 for Cardiologists, Part 14 Other sets in this series: Diabetes Mellitus …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 13
In this week’s Homerun Slides, we review the positives and negatives of sulfonylureas, comparing them with some of the newer medications available including incretins… To download these slides in PowerPoint (.ppt) format, use this link: Diabetes Mellitus 101 for Cardiologists, Part 13 Other sets in this series: Diabetes Mellitus 101 for Cardiologists, Part …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 12
In this week’s Homerun Slides, we continue our discussion of incretins and then examine the benefits of adding SGLT-2 inhibitors to patient medication regimens…. To download these slides in PowerPoint (.ppt) format, use this link: Diabetes Mellitus 101 for Cardiologists, Part 12 Other sets in this series: Diabetes Mellitus 101 for Cardiologists, Part …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 11
In this week’s Homerun Slides, we cover the importance of the Incretin Effect with an examination of the mechanisms of action of GLP-1 agonist and DPP-4 inhibitor drugs including the cardioprotective aspects of these medications…. To download these slides in PowerPoint (.ppt) format, use this link: Diabetes Mellitus 101 for Cardiologists, Part 11 …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 10
In this week’s Homerun Slides, we continue with our review of diabetes therapy from a cardiovascular perspective. We finish up our discussion of how to treat inflammation issues and move on to treating the whole biome including a look at probiotic, prebiotic, and antibiotic treatment of the abnormal gut biome…. To download …
Read More »ACCORD Analysis Suggests Intensive Glucose Lowering May Reduce Ischemic Cardiovascular Events
Higher A1C target recommended for patients over 65 with comorbidities… A team of Canadian and American researchers have analyzed data from the ACCORD trial to investigate whether the intensive lowering of glucose concentrations affects the risk of ischemic heart disease in patients with type 2 diabetes. The researchers assessed 10,251 …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 9
In this week’s Homerun Slides, Dr. Stanley Schwartz continues his review of pioglitazone as a therapy for both diabetes and cardiovascular issues. He shows how this medication is cardioprotective and that patients on this plus metformin do much better after hospitalization…. To download these slides in PowerPoint (.ppt) format, use this link: Diabetes …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.